Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jun-20 4:47 PM View:  | Campbell Bradley L Director | Progenics Pharmaceuticals I... (PGNX) | 19-Jun-20 | Disposition | 12,000 | -- | -- | (100%) 12.0K to 0 | |
| 23-Jun-20 4:48 PM View: | Ber Gerard Director | Progenics Pharmaceuticals I... (PGNX) | 19-Jun-20 | Disposition | 50,000 | -- | -- | (100%) 50.0K to 0 | |
| 23-Jun-20 4:48 PM View: | Wong Vivien EVP, Development | Progenics Pharmaceuticals I... (PGNX) | 19-Jun-20 | Disposition | 4,121 | -- | -- | (100%) 4.12K to 0 | |
| 23-Jun-20 4:49 PM View: | Osorio Benedict COO | Progenics Pharmaceuticals I... (PGNX) | 19-Jun-20 | Disposition | 21,202 | -- | -- | (100%) 21.2K to 0 | |
| 11-Sep-19 1:32 PM View: | Velan Capital, L.P. 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 09-Sep-19 | Purchase | 72,023 | $4.99 | $359,733.00 | < 1% 7.94M to 8.01M | |
| 09-Sep-19 6:14 PM View: | Lte Partners, LLC 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 09-Sep-19 | Purchase | 21,480 | $4.94 | $106,096.00 | 1% 1.93M to 1.95M | |
| 09-Sep-19 6:14 PM View: | Lte Partners, LLC 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 05-Sep-19 | Market Purchase | 43,520 | $4.62 | $201,097.00 | 2% 1.89M to 1.93M | (8%) |
| 05-Sep-19 4:37 PM View: | Velan Capital, L.P. 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 04-Sep-19 | Market Purchase | 243,614 | $4.51 | $1,098,530.00 | 3% 7.7M to 7.94M | (6%) |
| 05-Sep-19 4:37 PM View: | Velan Capital, L.P. 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 03-Sep-19 | Market Purchase | 277,424 | $4.39 | $1,218,920.00 | 4% 7.42M to 7.7M | (4%) |
| 27-Aug-19 3:45 PM View: | Velan Capital, L.P. 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 26-Aug-19 | Market Purchase | 73,230 | $4.30 | $314,911.00 | < 1% 7.35M to 7.42M | (2%) |
| 27-Aug-19 3:45 PM View: | Velan Capital, L.P. 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 23-Aug-19 | Market Purchase | 130,826 | $4.31 | $563,690.00 | 2% 7.21M to 7.35M | (2%) |
| 08-Jul-19 12:32 PM View: | Campbell Bradley L Director | Progenics Pharmaceuticals I... (PGNX) | 03-Jul-19 | Option Exercise | 12,000 | $4.89 | $58,680.00 | 100% 0 to 12.0K | |
| 03-Jul-19 8:56 AM View: | Scheinberg David A Director | Progenics Pharmaceuticals I... (PGNX) | 01-Jul-19 | Option Exercise | 10,000 | $5.33 | $53,300.00 | 22% 46.19K to 56.19K | |
| 27-Jun-19 4:33 PM View: | Crowley Peter J Director | Progenics Pharmaceuticals I... (PGNX) | 26-Jun-19 | Option Exercise | 50,000 | $5.35 | $267,300.00 | 100% 0 to 50.0K | |
| 15-Feb-17 5:13 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 15-Feb-17 | Market Sale | 150,000 | $9.55 | $1,432,500.00 | (2%) 7.15M to 7.0M | 49% |
| 15-Feb-17 5:13 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 14-Feb-17 | Market Sale | 352,600 | $9.69 | $3,417,220.00 | (5%) 7.5M to 7.15M | 49% |
| 15-Feb-17 5:13 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 13-Feb-17 | Market Sale | 100,000 | $9.70 | $970,000.00 | (1%) 7.6M to 7.5M | 50% |
| 09-Feb-17 4:40 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 09-Feb-17 | Market Sale | 201,300 | $9.70 | $1,953,590.00 | (3%) 7.8M to 7.6M | 50% |
| 09-Feb-17 4:40 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 07-Feb-17 | Market Sale | 150,000 | $9.71 | $1,456,500.00 | (2%) 7.95M to 7.8M | 50% |
| 13-Jan-17 4:28 PM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 11-Jan-17 | Disposition | 1,000,000 | $8.95 | $8,950,000.00 | (11%) 8.95M to 7.95M | 45% |
| 15-Jun-15 9:32 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Jun-15 | Option Exercise | 2,000 | $5.33 | $10,660.00 | 6% 35.05K to 37.05K | |
| 15-Jun-15 9:32 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Jun-15 | Market Option Sale (Planned) | 2,000 | $6.83 | $13,660.00 | (5%) 37.05K to 35.05K | 28% |
| 16-Mar-15 12:26 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 13-Mar-15 | Market Option Sale (Planned) | 3,000 | $7.00 | $21,000.00 | (8%) 38.05K to 35.05K | 30% |
| 16-Mar-15 12:26 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 13-Mar-15 | Option Exercise | 3,000 | $5.35 | $16,050.00 | 9% 35.05K to 38.05K | |
| 13-Mar-15 9:26 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Mar-15 | Option Exercise | 2,000 | $5.33 | $10,660.00 | 6% 35.05K to 37.05K | |
| 13-Mar-15 9:26 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Mar-15 | Market Option Sale (Planned) | 2,000 | $6.83 | $13,660.00 | (5%) 37.05K to 35.05K | 28% |
| 04-Mar-15 2:55 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 03-Mar-15 | Option Exercise | 5,000 | $4.70 | $23,500.00 | 14% 35.05K to 40.05K | |
| 04-Mar-15 2:55 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 03-Mar-15 | Market Option Sale | 5,000 | $6.49 | $32,450.00 | (12%) 40.05K to 35.05K | 25% |
| 13-Jan-15 1:48 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 12-Jan-15 | Market Option Sale | 2,000 | $7.06 | $14,112.00 | (5%) 37.05K to 35.05K | 31% |
| 13-Jan-15 1:48 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 12-Jan-15 | Option Exercise | 2,000 | $5.33 | $10,660.00 | 6% 35.05K to 37.05K | |
| 12-Dec-14 11:27 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Dec-14 | Option Exercise | 3,000 | $5.35 | $16,050.00 | 9% 35.05K to 38.05K | |
| 12-Dec-14 11:27 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Dec-14 | Market Option Sale | 3,000 | $7.07 | $21,201.00 | (8%) 38.05K to 35.05K | 31% |
| 21-Nov-14 5:06 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 21-Nov-14 | Option Exercise | 9,000 | $5.35 | $48,150.00 | 26% 35.05K to 44.05K | |
| 21-Nov-14 5:06 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 21-Nov-14 | Market Option Sale | 9,000 | $7.00 | $63,000.00 | (20%) 44.05K to 35.05K | 30% |
| 14-Nov-14 10:00 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 13-Nov-14 | Option Exercise | 10,000 | $5.33 | $53,300.00 | 29% 35.05K to 45.05K | |
| 14-Nov-14 10:00 PM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 13-Nov-14 | Market Option Sale | 10,000 | $6.83 | $68,300.00 | (22%) 45.05K to 35.05K | 28% |
| 12-Nov-14 9:31 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Nov-14 | Option Exercise | 5,000 | $5.03 | $25,150.00 | 14% 35.05K to 40.05K | |
| 12-Nov-14 9:31 AM View: | Israel Robert J Executive Vice President, Medi | Progenics Pharmaceuticals I... (PGNX) | 11-Nov-14 | Market Option Sale | 5,000 | $6.53 | $32,650.00 | (12%) 40.05K to 35.05K | 25% |
| 23-Jul-14 10:42 AM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 21-Jul-14 | Market Purchase | 388,659 | $4.73 | $1,838,360.00 | 5% 8.56M to 8.95M | 4% |
| 23-Jul-14 10:42 AM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 18-Jul-14 | Market Purchase | 388,200 | $4.73 | $1,836,190.00 | 5% 8.17M to 8.56M | 4% |
| 23-Jul-14 10:42 AM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 17-Jul-14 | Market Purchase | 436,884 | $4.48 | $1,957,240.00 | 6% 7.74M to 8.17M | 9% |
| 23-Jul-14 10:42 AM View: | Broadfin Healthcare Master ... 10% Owner | Progenics Pharmaceuticals I... (PGNX) | 16-Jul-14 | Market Purchase | 411,693 | $4.48 | $1,844,380.00 | 6% 7.33M to 7.74M | 9% |
| 22-Jul-13 1:16 PM View: | Israel Robert J Senior VP Medical Affairs | Progenics Pharmaceuticals I... (PGNX) | 18-Jul-13 | Option Exercise | 5,000 | $5.33 | $26,650.00 | 14% 35.05K to 40.05K | |
| 22-Jul-13 1:16 PM View: | Israel Robert J Senior VP Medical Affairs | Progenics Pharmaceuticals I... (PGNX) | 18-Jul-13 | Market Option Sale (Planned) | 5,000 | $6.33 | $31,650.00 | (12%) 40.05K to 35.05K | 23% |
| 28-Mar-13 9:24 AM View: | Baker Mark Robert CEO Director | Progenics Pharmaceuticals I... (PGNX) | 27-Mar-13 | Market Purchase (Planned) | 650 | $5.32 | $3,458.00 | < 1% 160.49K to 161.14K | (8%) |
| 22-Mar-13 5:14 PM View: | Scheinberg David A Director | Progenics Pharmaceuticals I... (PGNX) | 22-Mar-13 | Option Exercise | 1,250 | $2.47 | $3,086.25 | 3% 46.19K to 47.44K | |
| 22-Mar-13 5:14 PM View: | Scheinberg David A Director | Progenics Pharmaceuticals I... (PGNX) | 22-Mar-13 | Option Exercise | 1,250 | $4.81 | $6,011.25 | (3%) 47.44K to 46.19K | (2%) |
| 28-Feb-13 5:24 PM View: | Baker Mark Robert CEO Director | Progenics Pharmaceuticals I... (PGNX) | 27-Feb-13 | Market Purchase (Planned) | 1,262 | $2.72 | $3,434.45 | < 1% 159.23K to 160.49K | 80% |
| 23-Jan-13 9:59 AM View: | Baker Mark Robert CEO Director | Progenics Pharmaceuticals I... (PGNX) | 22-Jan-13 | Market Purchase (Planned) | 1,215 | $2.82 | $3,429.45 | < 1% 158.01K to 159.23K | 74% |
| 26-Dec-12 1:05 PM View: | Baker Mark Robert CEO Director | Progenics Pharmaceuticals I... (PGNX) | 26-Dec-12 | Market Purchase (Planned) | 1,142 | $3.01 | $3,437.42 | < 1% 156.87K to 158.01K | 63% |
